
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
The Readout Loud
00:00
Telehealth
An increasing number of drug companies have embraced the powerful tool of online prescribing. To health policy experts, it's an innovation that could lead to poor care and inflated costs. Our colleague Katie Palmer wrote a story this week in stat on that very phenomenon.
Transcript
Play full episode